Back to News
Market Impact: 0.3

MOH Crosses Above Average Analyst Target

MOHNDAQ
Analyst EstimatesAnalyst InsightsCompany FundamentalsInvestor Sentiment & PositioningMarket Technicals & Flows
MOH Crosses Above Average Analyst Target

Molina Healthcare Inc (MOH) shares have recently traded at $324.88, surpassing the average analyst 12-month target price of $323.00. This development typically prompts analysts to either upgrade their price targets or downgrade on valuation, signaling to institutional investors the need to reassess MOH's current valuation and future growth prospects, given the diverse range of individual analyst opinions contributing to the average target.

Analysis

Molina Healthcare (MOH) shares have breached the average 12-month analyst price target of $323.00, with recent trading at $324.88 per share. This event creates a critical valuation juncture, suggesting the stock's momentum may have outpaced the existing consensus. The average target itself masks significant dissent among the 11 analysts covering the stock, with individual targets ranging widely from a low of $281.00 to a high of $397.00, reflected in a standard deviation of $32.323. While the overall ratings lean positive—with 6 strong buys and 1 buy—the presence of 4 holds and 1 strong sell indicates a lack of uniform conviction. Notably, these ratings have remained static for the past two months, implying the recent price appreciation has occurred without a corresponding shift in analyst sentiment, thereby increasing the focus on whether upcoming fundamental developments will justify either target price upgrades or valuation-based downgrades.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment